5-methyl-1-(propan-2-yl)-2,3-dihydro-1H-pyrazol-3-one, 97%, 250mg

7-Bromoisoquinoline, 97.0%, 5g

1H-Benzimidazole-2-sulfonic acid, 98.0%, 5g

1-(Pyridazin-4-yl)ethanone, 95.0%, 250mg

(R)-2-Hydroxypropanoic acid, 95.0%, 1kg

5-Aminopyridine-3-sulfonamide, 97%, 250mg

Naphthalene-1,5-diol, 95.0%, 250g

N,N-diméthylformamide, min 99,5 %, pour la synthèse, 25 l, emballage plastique.

Ethyl 1-methyl-4-oxocyclohexanecarboxylate, 95.0%, 250mg

trans-1,3-Cyclohexanediamine>97.0%(T)200mg

6-Chloro-3-cyclopropyl-[1,2,4]triazolo[4,3-b]pyridazine, 95.0%, 500mg

6-Bromobenzo[d][1,3]dioxole-4-carbaldehyde, 95+%, 1g

3,3-diethoxyprop-1-yne, 95.0%, 25g